These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11122115)

  • 1. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
    Mugneret F; Chaffanet M; Maynadié M; Guasch G; Favre B; Casasnovas O; Birnbaum D; Pébusque MJ
    Br J Haematol; 2000 Nov; 111(2):647-9. PubMed ID: 11122115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
    Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
    Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
    Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
    Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
    Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
    Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12).
    Suzan F; Guasch G; Terre C; Garcia I; Bastie JN; Maarek O; Ribaud P; Gluckman E; Daniel MT; Pébusque MJ; Castaigne S
    Br J Haematol; 2003 Apr; 121(2):312-4. PubMed ID: 12694254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
    Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
    Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
    Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
    J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
    Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.
    Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A
    Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455
    [No Abstract]   [Full Text] [Related]  

  • 18. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes.
    Belloni E; Trubia M; Gasparini P; Micucci C; Tapinassi C; Confalonieri S; Nuciforo P; Martino B; Lo-Coco F; Pelicci PG; Di Fiore PP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):320-5. PubMed ID: 15609342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
    Vizmanos JL; Hernández R; Vidal MJ; Larráyoz MJ; Odero MD; Marín J; Ardanaz MT; Calasanz MJ; Cross NC
    Hematol J; 2004; 5(6):534-7. PubMed ID: 15570299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.